Evry-Courcouronnes
France
16
2026-05-21
3
2026-03-24
These are the the leading inventors for applications assigned to Genethon:
Genethon based in Evry-Courcouronnes, FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
HYBRID AAV VECTOR ENHANCING TRANSGENE EXPRESSION IN THE LIVER
#2 | 2026-02-26Immunotherapy of Skeletal Myopathies Using ANTI-FAP CAR-T Cells
#3 | 2025-02-06Gene Therapy of Fibroblast Growth Factor 23 Related Hypophosphatemic Diseases
#4 | 2024-06-27Peptide-Modified AAV Capsid
#5 | 2023-10-12 ✅ Patent 12,582,723 granted on 2026-03-24NOVEL POLYNUCLEOTIDES ENCODING A HUMAN FKRP PROTEIN
#6 | 2023-09-07Treatment of Dilated Cardiomyopathies
#7 | 2023-08-31Enhancing Utrophin Expression in Cell by Inducing Mutations Within Utrophin Regulatory Elements and Therapeutic Use Thereof
#8 | 2023-08-24Treatment of Genetic Dilated Cardiomyopathies
#9 | 2023-08-10NRF2 Activator for Use in Treating Dilated Cardiomyopathies
#10 | 2023-08-03Method for Engineering Novel Hybrid AAV Capsids Through Hyper Variable Regions Swapping
#11 | 2023-07-13CILP-1 Inhibitors for Use in the Treatment of Dilated Cardiomyopathies
#12 | 2023-06-08Use of a Synthetic AAV Capsid for Gene Therapy of Muscle and Central Nervous System Disorders
#13 | 2022-09-08New Adeno-Associated Virus (AAV) Variants and Uses Thereof for Gene Therapy
#14 | 2022-07-21Peptide-Modified Hybrid Recombinant Adeno-Associated Virus Serotype Between AAV9 and AAVrh74 with Reduced Liver Tropism and Increased Muscle Transduction
#15 | 2022-06-30 ✅ Patent 12,466,864 granted on 2025-11-11PRODUCTION OF LARGE-SIZED QUASIDYSTROPHINS USING OVERLAPPING AAV VECTORS
#16 | 2021-09-23 ✅ Patent 12,637,668 granted on 2026-05-26MINI-GDE FOR THE TREATMENT OF GLYCOGEN STORAGE DISEASE III
Also check out GENETHON's (EVRY-COURCOURONNES, France) applicant profile with 12 patent applications submitted.
326213 ⎘